Epidemiological data of staphylococcal scalded skin syndrome in France from 1997 to 2007 and microbiological characteristics of Staphylococcus aureus.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

O. Dauwalder, L. Landrieve, F. Laurent, M. de Montclos, F
Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia—results of a prospective observational.
Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas,
New epidemiology of Staphylococcus aureus infection in Asia
C.N. van Ettekoven, D. van de Beek, M.C. Brouwer 
Gut bacterial microbiota and obesity
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and.
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects  K. Ekelund, P. Skinhøj, J. Madsen, H.B.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
A guide to interpreting economic studies in infectious diseases
E. Lindberg, I. Adlerberth, A.E. Wold 
Clinical impact of antibiotic-resistant Gram-positive pathogens
Cost-effectiveness of universal MRSA screening on admission to surgery
N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A
Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock  T. Ferry, D. Thomas,
Genital Chlamydia trachomatis infections
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
J. S. Casalegno, M. Ottmann, M. Bouscambert Duchamp, V. Escuret, G
J. S. Casalegno, M. Ottmann, M. Bouscambert Duchamp, V. Escuret, G
Nocardiosis in Quebec, Canada, 1988–2008
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Pharmacodynamics of doxycycline
Do we need new antibiotics?
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Bacterial resistance—the clinical challenge
Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008  C.-K. Tan, C.-C.
Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.
A. Potron, J. Kalpoe, L. Poirel, P. Nordmann 
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
K.J. Psoter, A.J. De Roos, J. Wakefield, J. Mayer, M. Rosenfeld 
Recent developments in staphylococcal scalded skin syndrome
Systematic review of antibiotic consumption in acute care hospitals
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000  T. Benfield, F. Espersen,
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
The role of antimalarial treatment in the elimination of malaria
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals  G.L. Cartolano,
Staphylococcal chromosome cassette evolution in Staphylococcus aureus inferred from ccr gene complex sequence typing analysis  G. Lina, G. Durand, C.
P.M. Hawkey  Clinical Microbiology and Infection 
Correlation between clinical data and antibiotic resistance in coagulase-negative Staphylococcus species isolated from 68 patients with acute post-cataract.
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Effect of antibiotics, alone and in combination, on Panton–Valentine leukocidin production by a Staphylococcus aureus reference strain  O. Dumitrescu,
Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals  M.E. Reverdy, S. Jarraud, S. Bohin-Duhreux, E.
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Real-time comparative monitoring of the A/H1N1 pandemic in France
E. Tacconelli  Clinical Microbiology and Infection 
Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus  J.A.
O. Dauwalder, L. Landrieve, F. Laurent, M. de Montclos, F
Serum antibodies against Panton–Valentine leukocidin in a normal population and during Staphylococcus aureus infection  M. Croze, O. Dauwalder, O. Dumitrescu,
Modelling during an emergency: the 2009 H1N1 influenza pandemic
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
W. Witte  Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Typing of Clostridium difficile
L. Blairon, Y. De Gheldre, B. Delaere, A. Sonet, A. Bosly, Y
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
The future of diagnostic bacteriology
Presentation transcript:

Epidemiological data of staphylococcal scalded skin syndrome in France from 1997 to 2007 and microbiological characteristics of Staphylococcus aureus associated strains  V. Lamand, O. Dauwalder, A. Tristan, J.S. Casalegno, H. Meugnier, M. Bes, O. Dumitrescu, M. Croze, F. Vandenesch, J. Etienne, G. Lina  Clinical Microbiology and Infection  Volume 18, Issue 12, Pages E514-E521 (December 2012) DOI: 10.1111/1469-0691.12053 Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Distribution of the number of cases of staphylococcal scalded skin syndrome (SSSS), generalized exfoliative syndrome (GES) and localized bullous impetigo (BI) per year and per year estimated incidence of SSSS cases according to the French National Reference Centre of staphylococci notifications from 1997 to 2007. Annual estimated incidences of SSSS cases (dotted curve and secondary scale in grey) were calculated with the French population data provided by the French ‘Institut National des Statistiques et des Etudes Economiques' and available from http://www.insee.fr/fr/themes/tableau.asp?reg_id=0&ref_id=NATnon02145. Clinical Microbiology and Infection 2012 18, E514-E521DOI: (10.1111/1469-0691.12053) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Distribution of staphylococcal scalded skin syndrome presentations over the seasons. BI, localized bullous impetigo; GES, generalized exfoliative syndrome. p calculated using a chi-square test. Clinical Microbiology and Infection 2012 18, E514-E521DOI: (10.1111/1469-0691.12053) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions